Status:
COMPLETED
Polycystic Ovary Syndrome - Improving Outcomes
Lead Sponsor:
Baker Heart and Diabetes Institute
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
Polycystic ovary syndrome affects a striking 9-18% of Australian reproductive aged women and has been associated with a number of metabolic abnormalities. Given the strong correlation between metabol...
Eligibility Criteria
Inclusion
- Overweight and class I obese pre-menopausal women
- Diagnosis of PCOS by Rotterdam criteria
Exclusion
- Any current medication
- pregnancy or the desire to become pregnant
- BMI \> 35
- a history of type I diabetes, secondary hypertension not due to PCOS
- cardiovascular, cerebrovascular, liver or thyroid disease
- severe mental illness.
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01504321
Start Date
May 1 2012
End Date
December 1 2015
Last Update
November 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Centre, Alfred Hospital
Prahran, Victoria, Australia, 3004